Public input shaped the 2026-2035 National Plan to Address Alzheimer's Disease and Related Dementias. The federal strategy now centers on risk reduction, research, care, and family support through 2035. The National Plan is the federal roadmap for Alzheimer's and related dementias. For spouses and partners, the practical questions are coverage, cost, and access to help at home.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What did public input change?
- Will Medicare cover Leqembi for my spouse?
- What will treatment cost a couple?
- Can we get navigation and respite at home?
- What should spouses verify first?
What did public input change?
Federal officials invited comments through listening sessions and a written request under docket HHS-ASPE-2026-0298, with comments due Aug. 15, 2026. That input will guide federal efforts through 2035.
HHS then announced the 2026 Update on Oct. 22, 2026, according to the HHS announcement. It replaced six historic goals with four goals on risk reduction, research, care, and family support. It also added related dementias to the title, reflecting public input.
Will Medicare cover Leqembi for my spouse?
Medicare covers FDA-approved Leqembi broadly after traditional approval, according to the CMS coverage statement. Coverage is not automatic for every diagnosis.
It requires specific clinical and enrollment conditions. Ask the care team to check each item before planning treatment:.
- enrollment in Medicare
- mild cognitive impairment or mild dementia
- documented amyloid pathology
- clinician and patient participation in a CMS registry
What will treatment cost a couple?
Leqembi lists at about $26,500 per year, according to the KFF cost analysis. Traditional Medicare beneficiaries owe 20% Part B coinsurance. That means more than $5,000 yearly out of pocket without Medigap or other supplemental coverage. The wider burden is also large.
The Alzheimer's Association reports more than 7 million Americans live with Alzheimer's. It reports nearly 13 million unpaid caregivers provided over 19 billion hours valued above $446 billion, with families bearing 70% of lifetime dementia-care costs. Health and long-term care for dementia will cost about $409 billion in 2026. Medicare and Medicaid will cover about $263 billion. Families will pay about $103 billion out of pocket.
Can we get navigation and respite at home?
The voluntary 8-year GUIDE Model may help some couples, according to the CMS GUIDE Model page. It launched July 1, 2024 and runs through 2032. It pays participating providers for dementia care navigation, 24/7 support, and caregiver education.
Eligible home-dwelling traditional-Medicare beneficiaries can receive up to $2,500 yearly in respite. Availability depends on local participation, so spouses should confirm whether a nearby practice joined GUIDE. Medicare Advantage enrollment does not qualify under this pathway.
What should spouses verify first?
Disease-modifying drugs and GUIDE help only narrow groups. Drugs fit early-stage confirmed amyloid cases in a registry.
GUIDE fits home-dwelling traditional-Medicare patients with a participating provider. Confirm diagnosis stage, amyloid testing, registry enrollment, and supplemental coverage before scheduling infusions. Then call local GUIDE participants, ask about intake criteria, and request a written estimate of drug coinsurance, travel, monitoring visits, and respite coverage.
You Might Also Like
- The 2026 NIA Workshop on Comprehensive Dementia Care Models: A 2026 Follow-Up Checklist for Spouses and Partners
- Strengths-Based Dementia Care in the 2026 NIA Report: What Changed and What Comes Next for Spouses and Partners
- Home-Based Dementia Care Research Priorities in 2026: What the Report Establishes and Leaves Unanswered for Spouses and Partners
